Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The interleukin-1 and interleukin-10 gene polymorphisms in primary sclerosing cholangitis: no associations with disease susceptibility/resistance.

Journal of hepatology - 1 Jun 2000

Donaldson P T, Norris S, Constantini P K, Bernal W, Harrison P, Williams R

Abstract excerpt

BACKGROUND/AIMS: Although primary sclerosing cholangitis is believed to be an autoimmune disorder, no tissue-specific auto-antibodies have yet been identified, and the strongest support for an autoimmune aetiology comes from HLA-association studies. Three different HLA haplotypes are associated with susceptibility to the disease and one with protection from it. These HLA haplotypes, however, do not account for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholangitis, Sclerosing
Share to Inflammatory Bowel Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interleukin-1

Share to Interleukin 1 Receptor Antagonist Protein

Share to Interleukin-10

Share to Microsatellite Repeats

Share to Reference Values

Share to Sialoglycoproteins

Source

Identifiers

PMID: 10898307
DOI: 10.1016/s0168-8278(00)80091-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The interleukin-1 and interleukin-10 gene polymorphisms in primary sclerosing cholangitis: no associations with disease susceptibility/resistance.PMID 10898307Read ↗

No evidence for involvement of the interleukin-10 -592 promoter polymorphism in genetic susceptibility to primary biliary cirrhosis.Semantic proximity Read ↗

Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitisSemantic proximity Read ↗

Association of single nucleotide polymorphisms of the interleukin-10 promoter gene and susceptibility to primary biliary cirrhosis: immunogenetic differences in Italian and Japanese patients.Semantic proximity Read ↗

Meta-Analysis of the Relation Between IL10 Promoter Polymorphisms and Autoimmune Liver Disease Risk.Semantic proximity Read ↗

Genetic association between interleukin-10 promoter region polymorphisms and primary Sjögren's syndrome.Semantic proximity Read ↗

Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitis.Semantic proximity Read ↗

Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis.Semantic proximity Read ↗

The IL-10 gene is not involved in the predisposition to inflammatory bowel disease.Semantic proximity Read ↗

HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility.Semantic proximity Read ↗

Interleukin-1, interleukin-10 and tumour necrosis factor-alpha gene polymorphisms in hepatitis C virus infection: an investigation of the relationships with spontaneous viral clearance and response to alpha-interferon therapy.Semantic proximity Read ↗

Absence of a genetic association between IL-1RN and IL-1B gene polymorphisms in ulcerative colitis and Crohn disease in multiple populations from northeast England.Semantic proximity Read ↗

No major effect of the CD28/CTLA4/ICOS gene region on susceptibility to primary sclerosing cholangitis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.